Improving cancer prevention trial processes
Improving the Processes around Approval, Accrual and Translational Research in Cancer Prevention Trials
['FUNDING_OTHER'] · UNIVERSITY OF KANSAS MEDICAL CENTER · NIH-10782131
This study is all about finding better ways to help people join clinical trials that focus on preventing cancer before it starts, and it will involve testing new cancer vaccines and markers to improve health outcomes for patients at the University of Kansas Cancer Center.
Quick facts
| Phase | ['FUNDING_OTHER'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF KANSAS MEDICAL CENTER (nih funded) |
| Locations | 1 site (KANSAS CITY, UNITED STATES) |
| Trial ID | NIH-10782131 on ClinicalTrials.gov |
What this research studies
This research focuses on enhancing the processes that support clinical trials aimed at intercepting cancer, particularly at the University of Kansas Cancer Center. It aims to establish efficient methods for patient accrual and trial approval, emphasizing active strategies to prevent cancer before it develops. The project will involve collaboration with various cancer prevention and control programs, leveraging existing research and clinical expertise to improve outcomes. Patients may be involved in trials that test innovative cancer vaccines and biomarkers.
Who could benefit from this research
Good fit: Ideal candidates for participation are individuals at high risk for gastrointestinal cancers, particularly those with familial predispositions.
Not a fit: Patients with advanced cancer or those not at risk for gastrointestinal malignancies may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to more effective cancer prevention strategies and improved patient outcomes.
How similar studies have performed: Previous research in cancer interception has shown promise, indicating that proactive approaches can significantly impact cancer prevention.
Where this research is happening
KANSAS CITY, UNITED STATES
- UNIVERSITY OF KANSAS MEDICAL CENTER — KANSAS CITY, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: BANSAL, AJAY — UNIVERSITY OF KANSAS MEDICAL CENTER
- Study coordinator: BANSAL, AJAY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: Cancer Center, Cancer Control, Cancer Control Research Program, Cancer Control Science, Cancer Prevention Trial